Alnylam Pharmaceuticals, Inc. (ALNY): Narxning sotuvga nisbati

Alnylam Inc. (ALNY) kompaniyasining korporativ logotipi

Alnylam Pharmaceuticals noyob patologiyalar uchun taklif etilayotgan o'ziga xos terapiyalar tufayli elastik bo'lmagan talabga tayanadi. Kompaniyaning GURU.Markets platformasidagi normallashtirilgan P/S ko'rsatkichi bozor kutganlarini aks ettiradi, bunda 4.40 joriy metrika darajasini ifodalaydi. Professional boshqaruv RNA interferentsiyasini ishlab chiqishda shaffoflikni ta'minlaydi va to'liq mustaqillikka intiladi. Zamonaviy biotexnologik quvvatlar rejalashtirilgan liniyalarni modernizatsiya qilish jarayonida barqaror ishlamoqda.

ALNY: Alnylam Pharmaceuticals P/S multiplikatori 04.07.2022 - 16.11.2026

alnylam.com (ALNY) kompaniyasi koʻrsatkichlari kesimi va tahlili

- birja kapitallashuvi ma'lumotlari:
Kompaniyaning umumiy tahlili:ALNY Alnylam
Alnylam Pharmaceuticals tayyor mahsulotlari

P/S koeffitsiyenti biznesning bozor kapitalizatsiyasini uning yillik daromadiga nisbatda ko'rsatadi, bu esa investorga sotuvlar birligi uchun to'langan premiumni aniqlash imkonini beradi. Sotuvlar nisbati orqali ifodalangan 4.40 ning joriy qiymati Alnylam Pharmaceuticals (ALNY) kompaniyasining RNA interferensiyasi sohasidagi patent monopoliyasi uchun premiumni aks ettiradi va kompaniyaning yuqori marjalarining fundamental barqarorligini hamda noyob kasalliklar bozoridagi yetakchiligini tasdiqlaydi.

Raqobatdosh kompaniyalar

VRTX (Vertex Pharmaceuticals Incorporated) - Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati Insmed INSM|UTHR (United Therapeutics Corp.) - Narxning sotuvga nisbati|BioMarin Pharmaceutical - P/S multiplikatori|Bozor kapitallashuvining daromadga nisbati BBIO (BridgeBio Pharma, Inc.)|BGM Group Corp (BGM) - Narxning daromadga nisbati|Cogent Biosciences Inc (COGT) - P/S multiplikatori|Narxning daromadga nisbati Xeris Biopharma Inc|KROS: Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati arcturusrx.com (ARCT)|Kapitalizatsiyaning daromadga nisbati Eton Pharmaceuticals ETON|P/S multiplikatori KMDA (kamada.com)|P/S multiplikatori Fulcrum Therapeutics, Inc. FULC|Abeona Therapeutics - P/S multiplikatori|mereobiopharma.com (MREO) - Kapitalizatsiyaning daromadga nisbati|Protalix BioTherapeutics Inc. (PLX) - Narxning daromadga nisbati|PLRX (Pliant Therapeutics Inc) - Narxning daromadga nisbati|Narxning daromadga nisbati Applied Therapeutics, Inc.|Rein Therapeutics Inc. (RNTX) - Narx/daromad koeffitsiyenti|Kapitalizatsiyaning daromadga nisbati GELS (Gelteq Limited)|P/S multiplikatori Aytu Therapeutics (AYTU)|Narxning daromadga nisbati Chemomab Therapeutics Ltd. CMMB|Bozor kapitallashuvining daromadga nisbati SRXH|Polyrizon Limited - P/S multiplikatori|AEZS (zentaris.com) - Kapitalizatsiya va daromad nisbati|CYTH (Cyclo Therapeutics, Inc.) - Kapitalizatsiyaning daromadga nisbati|Sotuvga nisbatan narx Inozyme Pharma, Inc. (INZY)|RPHM (Reneo Pharmaceuticals) - P/S multiplikatori|COSCIENS Biopharma (CSCI) - Narx/daromad koeffitsiyenti